Aclarion, Inc. (ACON)
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.
Sector: Services-Medical Laboratories
Industry: Medical - Healthcare Information Services
Aclarion, Inc.
NASDAQ:ACONHealthcare · Medical - Healthcare Information Services
-1.02%$1.95
AH$1.93-0.95%vs close
Mkt Cap$5.62M
Float2.88M
O/S2.88M
Vol
$ Vol
RVOL
Inst Own4.0%
SI0.8%
Earnings
Dilution
Financials Summary
Revenue$76K
Net Income-$7.23M
Total Assets$13.67M
Free Cash Flow-$7.19M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$12.84M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:9,045Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:27Reverse splitMar 28, 202527 shares → 1
- 1:335Reverse splitJan 30, 2025335 shares → 1
- 1:16Reverse splitJan 4, 202416 shares → 1
Balance Sheet Details
Assets$13.67M
Liabilities$837K
Accounts Receivable$30K
Accounts Payable$324K
Inventory$0
PP&E (Net)$24K
Goodwill$0
Intangible Assets$1.25M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $76K | $46K | $75K | $60K | $60K | $49K | $27K |
| YoY Growth | 65.6% | -39.4% | 24.8% | 0.3% | 23.9% | 80.9% | - |
| Cost of Revenue | $296K | $130K | $76K | $65K | $69K | $66K | $63K |
| Gross Profit | -$221K | -$84K | -$324 | -$5K | -$9K | -$18K | -$36K |
| Gross Margin | -291.3% | -183.8% | -0.4% | -8.0% | -14.7% | -36.2% | -134.9% |
| Research and Development | $1.03T | $889K | $873K | $1.07M | $788K | $1.05M | $1.74M |
| Selling, General, and Administrative | $6.03T | $4.59M | $4M | $4.49M | $2.16M | $1.41M | $2.24M |
| Other | -$7.06T | -$45K | $0 | $0 | $0 | $2M | $0 |
| Total Operating Expenses | $6.83M | $5.43M | $4.88M | $5.56M | $2.94M | $4.46M | $3.98M |
| Operating Income (EBIT) | -$7.05M | -$5.51M | -$4.88M | -$5.56M | -$2.95M | -$4.48M | -$4.01M |
| Operating Margin | -9312.5% | -12057.2% | -6466.5% | -9201.2% | -4897.9% | -9203.0% | -14921.0% |
| Interest Expense | $0 | $535K | $608K | $1.51M | $476K | $156K | $5K |
| Interest Income | $411K | $318 | $172 | $3K | $0 | $15 | $0 |
| Other Income (Expense) | -$181K | -$1.48M | -$35K | -$1.51M | -$2M | -$158K | -$6K |
| Income Before Tax (EBT) | -$7.23M | -$6.99M | -$4.91M | -$7.07M | -$4.95M | -$4.64M | -$4.02M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$7.23M | -$6.99M | -$4.91M | -$7.07M | -$4.95M | -$4.64M | -$4.02M |
| Net Income Margin | -9551.9% | -15293.8% | -6513.4% | -11694.4% | -8210.5% | -9527.3% | -14943.1% |
| Supplementary Data | |||||||
| EPS | -13.61 | -7480.22 | -79782.00 | -177396.00 | -120035.00 | -110583.00 | -97680.00 |
| Diluted EPS | -13.61 | -7480.22 | -79782.00 | -177396.00 | -120035.00 | -110583.00 | -97680.00 |
| Weighted Average OS | 532,036 | 943 | 62 | 42 | 50 | 50 | 50 |
| EBITDA | -$7.01M | -$6.26M | -$4.14M | -$5.42M | -$4.29M | -$4.28M | -$3.84M |
| EBITDA Margin | -9251.6% | -13700.3% | -5491.0% | -8962.7% | -7111.1% | -8803.1% | -14262.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $12.02M | $454K | $1.02M | $1.47M | $433K | $15K | $128K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $12.02M | $454K | $1.02M | $1.47M | $433K | $15K | $128K |
| Accounts Receivable | $30K | $18K | $13K | $19K | $6K | $23K | $15K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $25K | $134K | $152K | $60K | $20K | $0 | $0 |
| Total Current Assets | $12.4M | $824K | $1.29M | $1.7M | $732K | $97K | $219K |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $24K | $5K | $2K | $3K | $13K | $26K | $49K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1.25M | $1.29M | $1.17M | $1.21M | $1.14M | $1.17M | $1.16M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $1.28M | $1.3M | $1.17M | $1.21M | $1.16M | $1.19M | $1.21M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $13.67M | $2.12M | $2.46M | $2.91M | $1.89M | $1.29M | $1.43M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $324K | $532K | $761K | $458K | $1.06M | $860K | $501K |
| Short-Term Debt | $0 | $0 | $1.13M | $0 | $2M | $2.38M | $516K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $460K | $543K | $769K | $166K | $356K | $2M | $2.02M |
| Total Current Liabilities | $837K | $1.15M | $3.19M | $689K | $7.62M | $8.38M | $3.13M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $837K | $1.15M | $3.19M | $689K | $7.62M | $8.38M | $3.13M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $245 | $186 | $186 |
| Common Stock | $9 | $0 | $8 | $5 | $9 | $68 | $68 |
| Retained Earnings | -$58.5M | -$51.26M | -$44.28M | -$39.37M | -$31.89M | -$25.93M | -$20.44M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $71.33M | $52.23M | $43.55M | $41.6M | $26.16M | $18.85M | $18.74M |
| Total Equity | $12.84M | $970K | -$728K | $2.23M | -$5.73M | -$7.08M | -$1.7M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $13.67M | $2.12M | $2.46M | $2.91M | $1.89M | $1.29M | $1.43M |
| Supplementary Data | |||||||
| Total Debt | $0 | $0 | $1.13M | $0 | $2M | $2.38M | $516K |
| Net Debt | -$12.02M | -$454K | $105K | -$1.47M | $1.57M | $2.36M | $387K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$7.23M | -$6.99M | -$4.91M | -$7.07M | -$4.95M | -$4.64M | -$4.02M |
| Depreciation & Amortization | $227K | $193K | $163K | $144K | $186K | $196K | $178K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $105K | $287K | $456K | $1.29M | $177K | $26K | $28K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$11K | $7K | -$1K | -$12K | $16K | -$8K | -$15K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$199K | -$156K | $221K | -$603K | $200K | $342K | -$250K |
| Other Working Capital | -$148K | -$415K | $404K | -$703 | $460K | $205K | -$94K |
| Total Working Capital Change | -$358K | -$564K | $623K | -$616K | $676K | $540K | -$358K |
| Other Non-Cash Items | $95K | $1.8M | $23K | $1.3M | $1.56M | $2.08M | $0 |
| Net Cash from Operating | -$7.16M | -$5.27M | -$3.65M | -$4.95M | -$2.35M | -$1.79M | -$4.17M |
| Investing Activities | |||||||
| Capital Expenditures | -$204K | -$322K | -$120K | -$209K | -$152K | -$5K | -$22K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $1K | $0 | -$174K | -$245K |
| Net Cash from Investing | -$204K | -$322K | -$120K | -$208K | -$152K | -$179K | -$267K |
| Financing Activities | |||||||
| Debt Repaid | - | $301K | -$2.25M | $2M | - | - | - |
| Common Stock Issuance | $20.16M | $5.57M | $1.46M | $8.55M | $0 | $0 | $2K |
| Common Stock Repurchases | -$1.21M | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$1.25M | -$398K | -$365K | $0 | $0 | $0 |
| Net Cash from Financing | $18.95M | $5.03M | $3.31M | $6.19M | $2.94M | $1.86M | $2.95M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $11.58M | -$567K | -$452K | $1.03M | $438K | -$113K | -$1.49M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$7.16M | -$5.27M | -$3.65M | -$4.95M | -$2.35M | -$1.79M | -$4.17M |
| Capital Expenditure | -$22K | -$322K | -$120K | -$209K | -$1 | -$179K | -$267K |
| Free Cash Flow | -$7.19M | -$5.59M | -$3.77M | -$5.16M | -$2.35M | -$1.97M | -$4.44M |
| Cash at Beginning | $464K | $1.03M | $1.48M | $453K | $15K | $128K | $1.62M |
| Cash at End | $12.04M | $464K | $1.03M | $1.48M | $453K | $15K | $128K |